Literature DB >> 16091834

Frequent occurrence of protein isoforms with or without a single amino acid residue by subtle alternative splicing: the case of Gln in DRPLA affects subcellular localization of the products.

Keiko Tadokoro1, Mayu Yamazaki-Inoue1, Maki Tachibana1,2, Mina Fujishiro1,3, Kazuaki Nagao1, Masashi Toyoda1, Miwako Ozaki4, Masami Ono5, Nobuhiro Miki5, Toshiyuki Miyashita1, Masao Yamada6.   

Abstract

Protein isoforms with or without a single amino acid residue make a subtle difference. It has been documented on a few genes that alternative splicing generated such isoforms; however, the fact has attracted little attention. We became aware of a subtle sequence difference in DRPLA, a polyglutamine disease gene for dentatorubral pallidoluysian atrophy. Some reported cDNA sequences lacked 3 nucleotides (nt) (CAG), which were positioned apart from the expandable and polymorphic CAG repeats and also coded for glutamine. We experimentally confirmed that the difference was indeed generated by alternative splicing utilizing two acceptors separated by 3 nt. In DRPLA, the expression ratio of two mRNA isoforms was almost constant among tissues, with the CAG-included form being major. The glutamine-included protein isoform was more predominantly localized in the nucleus. Database searching revealed that alternative splice acceptors, as well as donors, are frequently situated very close to each other. We experimentally confirmed two mRNA isoforms of 3 nt difference in more than 200 cases by RT-PCR and found interesting features associated with this phenomena. Inclusion of 3 nt tends to result in single amino acid inclusion despite the phase of translational frame. The expression ratio sometimes varied extensively among tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091834     DOI: 10.1007/s10038-005-0261-9

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  39 in total

1.  An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing.

Authors:  K Chua; R Reed
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

3.  Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity.

Authors:  Frederick C Nucifora; Lisa M Ellerby; Cheryl L Wellington; Jon D Wood; William J Herring; Akira Sawa; Michael R Hayden; Valina L Dawson; Ted M Dawson; Christopher A Ross
Journal:  J Biol Chem       Date:  2002-12-02       Impact factor: 5.157

Review 4.  How prevalent is functional alternative splicing in the human genome?

Authors:  Rotem Sorek; Ron Shamir; Gil Ast
Journal:  Trends Genet       Date:  2004-02       Impact factor: 11.639

5.  Extended polyglutamine selectively interacts with caspase-8 and -10 in nuclear aggregates.

Authors:  M U; T Miyashita; Y Ohtsuka; Y Okamura-Oho; Y Shikama; M Yamada
Journal:  Cell Death Differ       Date:  2001-04       Impact factor: 15.828

6.  PCR detection of 9 polymorphisms in the WT1 gene.

Authors:  K Tadokoro; N Oki; A Sakai; H Fujii; A Ohshima; S Nagafuchi; T Inoue; M Yamada
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

7.  Dentatorubral-pallidoluysian atrophy protein interacts through a proline-rich region near polyglutamine with the SH3 domain of an insulin receptor tyrosine kinase substrate.

Authors:  Y Okamura-Oho; T Miyashita; K Ohmi; M Yamada
Journal:  Hum Mol Genet       Date:  1999-06       Impact factor: 6.150

8.  Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine.

Authors:  H Yanagisawa; M Bundo; T Miyashita; Y Okamura-Oho; K Tadokoro; K Tokunaga; M Yamada
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

Review 9.  Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs.

Authors:  Mark S Forman; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Med       Date:  2004-10       Impact factor: 53.440

10.  Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA).

Authors:  S Nagafuchi; H Yanagisawa; E Ohsaki; T Shirayama; K Tadokoro; T Inoue; M Yamada
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

View more
  35 in total

1.  Improving gene annotation using peptide mass spectrometry.

Authors:  Stephen Tanner; Zhouxin Shen; Julio Ng; Liliana Florea; Roderic Guigó; Steven P Briggs; Vineet Bafna
Journal:  Genome Res       Date:  2006-12-22       Impact factor: 9.043

2.  Single-nucleotide polymorphisms in NAGNAG acceptors are highly predictive for variations of alternative splicing.

Authors:  Michael Hiller; Klaus Huse; Karol Szafranski; Niels Jahn; Jochen Hampe; Stefan Schreiber; Rolf Backofen; Matthias Platzer
Journal:  Am J Hum Genet       Date:  2005-12-22       Impact factor: 11.025

3.  Assessing the fraction of short-distance tandem splice sites under purifying selection.

Authors:  Michael Hiller; Karol Szafranski; Rileen Sinha; Klaus Huse; Swetlana Nikolajewa; Philip Rosenstiel; Stefan Schreiber; Rolf Backofen; Matthias Platzer
Journal:  RNA       Date:  2008-02-11       Impact factor: 4.942

4.  It's a bit over, is that ok? The subtle surplus from tandem alternative splicing.

Authors:  Karol Szafranski; Marcel Kramer
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

5.  Genome-wide study of NAGNAG alternative splicing in Arabidopsis.

Authors:  Yanjing Shi; Guangli Sha; Xiaoyong Sun
Journal:  Planta       Date:  2013-10-06       Impact factor: 4.116

6.  A subtle alternative splicing event of the Na(V)1.8 voltage-gated sodium channel is conserved in human, rat, and mouse.

Authors:  Jana Schirmeyer; Karol Szafranski; Enrico Leipold; Christian Mawrin; Matthias Platzer; Stefan H Heinemann
Journal:  J Mol Neurosci       Date:  2009-12-02       Impact factor: 3.444

Review 7.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

8.  Sequence features involved in the mechanism of 3' splice junction wobbling.

Authors:  Kuo-Wang Tsai; Wen-Ching Chan; Chun-Nan Hsu; Wen-Chang Lin
Journal:  BMC Mol Biol       Date:  2010-05-07       Impact factor: 2.946

9.  Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties.

Authors:  Ginny Marie Harris; Katerina Dodelzon; Lijie Gong; Pedro Gonzalez-Alegre; Henry L Paulson
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

10.  Molecular determinants and evolutionary dynamics of wobble splicing.

Authors:  Jianning Lv; Yun Yang; Heng Yin; Fengjiao Chu; Haitao Wang; Wenjing Zhang; Yaozhou Zhang; Yongfeng Jin
Journal:  Mol Biol Evol       Date:  2009-02-12       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.